Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc (AMS.L) on 29th July 2026.
The filing was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc submitted the disclosure in its capacity as an exempt principal trader dealing in a client-serving capacity during the relevant period.
The bank holds a notable relationship with the company, as Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc.
In terms of purchase activity, Investec bought 419,640 ordinary shares, with prices ranging from a low of 280 pence to a high of 280.25 pence per unit.
On the sales side, the bank sold 550,000 ordinary shares at a consistent price of 280 pence per unit throughout the session.
The volume of shares sold exceeded the volume purchased during the same dealing day, reflecting notable two-way activity in the stock.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, options, or agreements that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The bank equally confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of securities referenced by any derivative instrument.
The disclosure was formally dated 30th July 2026, with contact for the filing attributed to Priyali Bhattacharjee, reachable via the telephone number listed in the regulatory submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a recognised Regulatory Information Service to ensure market transparency.
